On the promoting action of tamoxifen in a model of hepatocarcinogenesis induced by p-dimethylaminoazobenzene in CF1 mice

International Journal of Biochemistry and Cell Biology

Volumn 33, Issue 7, 2001, Pages 681-690

  Caballero, Fabiana ^a   Gerez, Esther ^a   Oliveri, Leda ^a   Falcoff, Nora ^b   Batlle, Alcira ^a,c   Vazquez, Elba ^a  

^a Centro de Investigaciones sobre Porfirinas y Porfirias   (Argentina)

^b Hospital 'Dr Bernardo Houssay'   (Argentina)

^c NONE   (Argentina)

Author keywords

Cytochrome P450; Hepatocarcinogenesis; Oxidative stress; P Dimethylaminoazobenzene; Tamoxifen

Indexed keywords

4 DIMETHYLAMINOAZOBENZENE; ANTINEOPLASTIC AGENT; CATALASE; CYTOCHROME P450; GLUTATHIONE TRANSFERASE; LIVER ENZYME; SUPEROXIDE DISMUTASE; TAMOXIFEN; TAMOXIFEN CITRATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEGRADATION; DIET; ENZYME ACTIVITY; HEME SYNTHESIS; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER HYPERPLASIA; LIVER INJURY; LIVER TUMOR; LONG TERM CARE; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; RESPONSE TIME;

5-AMINOLEVULINATE SYNTHETASE; ANIMALS; BODY WEIGHT; CARCINOGENS; CATALASE; CYTOCHROME P-450 ENZYME SYSTEM; GLUTATHIONE TRANSFERASE; HEME OXYGENASE (DECYCLIZING); LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; ORGAN SIZE; P-DIMETHYLAMINOAZOBENZENE; SUPEROXIDE DISMUTASE; TAMOXIFEN; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TIME FACTORS;

ANIMALIA;

EID: 0034995019     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(01)00056-5     Document Type: Article

References (32)

1. Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy
2. New perspective on cancer of the contralateral breast: A marker for assessing tamoxifen as preventive agent
3. Tamoxifen
4. Long-term prophylactic use of tamoxifen: Is it safe?
5. Tamoxifen induces hepatocellular carcinoma in rat liver: A one year study with two carcinogens
6. Review of the toxicology of tamoxifen
7. Genotoxic potential of tamoxifen and analogues in female Fischer F344/n rats, DBA/2 and C57B1/6 mice and in human MCL-5 cells
8. Tamoxifen induces short-term cumulative DNA damage and liver tumors in rats: Promotion by phenobarbital
9. DNA adducts formation by tamoxifen with rat and human liver microsomal activating systems
10. The effect of tamoxifen and two of its non-isomerizable fixed-ring analogues on multistage rat hepatocarcinogenesis
11. Chemoprevention of breast cancer by tamoxifen: Risks and opportunities
12. Induction and promotion of gamma-glutamyltranspeptidase-positive foci in the liver of female rats treated with ethinyl estradiol, clomiphene, tamoxifen and their associations
13. Studies of tamoxifen as a promoter of hepatocarcinogenesis in female Fischer F344 rats
14. Altered heme pathway regulation and drug metabolizing enzyme system in a mouse model of hepatocarcinogenesis. Effect of veronal
15. Drug metabolizing enzyme system and heme pathway in hepatocarcinogenesis
16. Hepatic enzymatic metabolism alteration and oxidative stress during the onset of carcinogenesis: Protective role of alpha tocopherol
17. δ-aminolevulinic acid synthetase. I. Studies in liver homogenates
18. Purification and properties of heme oxygenase from pig spleen microsomes
19. The carbon monoxide binding pigment of liver microsomes
20. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation
21. Assay of catalases and peroxidases
22. A sensitive spectrophotometric method for the determination of superoxide dismutase activity in tissue extracts
23. Formation of malondialdehyde from phospholipids arachidonate during microsomal lipid peroxidation
24. Protein measurement with the Folin-phenol reagent
25. Long-term tamoxifen therapy to control or to prevent breast cancer: Laboratory concept to clinical trial
26. Promotion potential of tamoxifen on hepatocarcinogenesis in female SD or F344 rats initiated with diethylnitrosamine
27. Induction of CYP2B1 and 3A1 and associated monooxygenase activities by tamoxifen and certain analogues in the liver of female rats and mice
28. Phase II enzyme expression in rat liver in response to the antiestrogen tamoxifen
29. A comparative study of tamoxifen metabolism in female rat, mouse and human liver microsomes
30. Glutathione peroxidase, superoxide dismutase, and catalase inactivation by peroxides and oxygen derived free radicals
31. Two-year carcinogenicity study of tamoxifen in Alderley Park Wistar-derived rats
32. Initiating activity of anti-estrogen tamoxifen but not toremifene in rat liver